IPL 2020: Disinfectant devices at players' dressing rooms?

Updated: 06 August, 2020 07:42 IST | Harit N Joshi | Mumbai

The device called Scalene Hypercharge Corona Canon (Shycocan) is mentioned in the SOP and will be installed in dressing rooms if available

Rohit Sharma and Quinton de Kock
Rohit Sharma and Quinton de Kock

The BCCI, it seems, is not leaving any stone unturned as far as safety of players and support staff is concerned as they set out to conduct the Indian Premier League in the United Arab Emirates.

In a draft Standard Operating Procedure (SOP) that the BCCI has shared with the eight franchises, one of the points in the dressing room section of the SOP, states that the BCCI is planning to instal a device that claims to neutralise "99.99 per cent" Coronavirus particles floating in a closed air space.

The device called Scalene Hypercharge Corona Canon (Shycocan) is mentioned in the SOP and will be installed in dressing rooms if available.

Shycocan was invented by a Bangalore-based firm and has got the US FDA nod. It is part of the medical and health SOP that BCCI shared with the franchisees.

Social distancing will be a must in the dressing room, according to the SOP.

Meanwhile, in Wednesday's meeting of the franchisees, it is learnt that the BCCI has agreed to bear the ground charges in the UAE. Generally, it is the teams who have to bear the costs. This step by the BCCI was taken to minimise losses the franchisees might face due to the sudden exit of title sponsors, Vivo.

Catch up on all the latest sports news and updates here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

First Published: 06 August, 2020 07:23 IST

Sign up for all the latest news, top galleries and trending videos from Mid-day.com

Subscribe
loading image
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK